Subjects must not be taking concomitant medications known to prolong the QT interval and have a risk of inducing Torsade de Pointes TdP Any concurrent medication with a known risk of inducing TdP that in the investigator 's opinion can not be discontinued will be allowed however these patients must be monitored closely 